Consolidated Balance Sheets Statement (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Cash and Cash Equivalents, at Carrying Value	$ 23,408	$ 29,332
Accounts Receivable, Net	170,707	170,805
Inventory, Net	58,181	53,214
Prepaid Expense and Other Assets	39,141	33,197
TOTAL CURRENT ASSETS	291,437	286,548
Property, Plant and Equipment, Net	118,665	115,295
Intangible Assets, Net (Excluding Goodwill)	8,335	8,221
Goodwill	163,337	162,787
Deferred Tax Assets, Net, Noncurrent	13,920	13,662
Other Assets, Noncurrent	26,979	24,360
TOTAL ASSETS	622,673	610,873
Accounts Payable, Current	51,280	57,639
Employee-related Liabilities, Current	26,188	34,028
Sales and Excise Tax Payable, Current	8,833	8,566
Deferred Revenue, Current	18,334	19,154
Taxes Payable, Current	3,814	6,527
Convertible Debt, Current	623	2,344
Other Accrued Liabilities, Current	17,105	14,937
TOTAL CURRENT LIABILITIES	126,177	143,195
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	206,053	223,075
Deferred Compensation Liability, Classified, Noncurrent	26,384	24,117
Deferred Tax Liabilities, Noncurrent	5,798	5,531
Other Liabilities, Noncurrent	34,108	33,300
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	1,376	1,376
Additional Paid in Capital, Common Stock	5,908	2,012
Retained Earnings (Accumulated Deficit)	363,903	283,660
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,712)	(1,739)
Treasury shares (at cost), xxx at 2011 and 4,218,726 at 2010	(149,088)	(107,406)
Total Core Laboratories N.V. shareholders' equity	220,387	177,903
Stockholders' Equity Attributable to Noncontrolling Interest	3,766	3,752
TOTAL EQUITY	224,153	181,655
TOTAL LIABILITIES AND EQUITY	$ 622,673	$ 610,873